Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

178541

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to Patient Safety Alert: Improving medication error incident reporting and learning, published by NHS England on 20 March 2014, which NHS trusts have (a) indentified a board-level director with responsibility for overseeing medication error incident reporting and learning, (b) e-mailed the contact details of a Medication Safety Officer to the Central Alerting System and (c) identified a multi-professional group to regularly review medication error incident reports.
tabling member constituency	Newcastle upon Tyne North
tabling member printed	Catherine McKinnell
uin	223770
answer	answer is ministerial correction date of answer 24/02/2015 answer text <p>Data was extracted on 10 February 2015 from the Central Alerting System (CAS) and the table attached shows that 244 trusts* have recorded that they have completed the actions required by the Alert including the information requested above.</p><p> </p><p> </p><p> </p><p><em>*Note:</em> This figure is based on the names that trusts are registered under in CAS.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 24/02/2015 14:27:11 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name Table of actions.docx title CAS- Trusts with contact details&completed actions
tabling member	4125 label Biography information for Catherine McKinnell

178543

registered interest
date	09/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to Patient Safety Alert: Improving medication error incident reporting and learning, published by NHS England on 20 March 2014, what progress he has made in developing the National Medication Safety Network; and what channels are available for patient groups to make representations to the National Medication Safety Network.
tabling member constituency	Newcastle upon Tyne North
tabling member printed	Catherine McKinnell
uin	223771
answer	answer is ministerial correction date of answer 24/02/2015 answer text <p>NHS England, in collaboration with the Medicines and Healthcare products Regulatory Agency (MHRA), has carried out the following activities in relation to developing the National Medication Safety Network:</p><p> </p><p> </p><p> </p><p>- Undertaken nine web events with presentations and recordings posted to the <a href="http://www.patientsafetyfirst.nhs.uk/" target="_blank">www.patientsafetyfirst.nhs.uk</a> web forum accessed by Medication Safety Officers (MSOs). A total of 699 MSOs have participated in these formal web meetings.</p><p> </p><p>- Run a conference for MSOs on 19 January 2015 with keynote speakers from NHS England, MHRA and the National Reporting and Learning System with 150 MSOs in attendance.</p><p> </p><p>- Run dedicated web events for the 18 Community Pharmacy MSOs.</p><p> </p><p>- Are arranging one-day regional meetings on 10 March 2015 (London), 15 July 2015 (Midlands) 12 May (South), 14 October (North) inviting 70-100 MSOs. A key aim of these events is to provide the opportunity for MSOs to feedback in person to NHS England and the MHRA on development of the MSO role.</p><p> </p><p>- We have dedicated (0.4 full-time equivalent) support for development of the MSO role from the Specialist Pharmacy Service. The remit includes monitoring of engagement by MSOs in the network.</p><p> </p><p> </p><p> </p><p>Although the NHS England Medication Safety team have not yet received any formal representations from national patient groups, MSOs have been encouraged to liaise with their local organisation ‘patient and public voice’ leads to help recruit patients onto their medication safety committees.</p><p> </p><p> </p><p> </p><p>Members of the public and patient groups can also make enquiries directly to NHS England.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 24/02/2015 14:08:53 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4125 label Biography information for Catherine McKinnell